Document is current
Any future updates will be listed below
-
Authors
Cui, Haotian https://orcid.org/0000-0001-8119-9485
Wang, Chloe
Maan, Hassaan https://orcid.org/0000-0002-3830-7177
Pang, Kuan https://orcid.org/0000-0003-3338-1738
Luo, Fengning
Duan, Nan https://orcid.org/0000-0002-3387-4674
-
Funding
Funding for this research was provided by:
Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (RGPIN-2020-06189)
Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (DGECR-2020-00294)
Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (Doctoral Fellowship)
University Health Network (Peter Munk Cardiac Centre AI Fund)
The AI Chairs Program funded by CIFAR, which is the Canadian Institute for Advanced Research, website at https://cifar.ca/
- License Information
-
More Information
Article History
Received: 12 July 2023
Accepted: 30 January 2024
First Online: 26 February 2024
Competing interests
: B.W. is on the advisory board of Vevo Therapeutics. N.D. is an employee of Microsoft and holds equity in the company. The remaining authors declare no competing interests.
